V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240007905 | 240010703 | 1.78 | 69 | Curative (C) | 2015-02-07 | 2015-02-07 | AML16 DA 3+10 | N | N | 240035016 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240007906 | 240010703 | 1.64 | 90 | null | 2013-05-08 | 2013-05-11 | PACLITAXEL | null | N | 240035016 | BEVACIZUMAB |
| 240007907 | 240004877 | null | null | Disease modification (D) | 2016-01-22 | 2016-01-22 | CLADRIBINE | N | N | 240035021 | FCR |
| 240007908 | 240004877 | 1.35 | 62.6 | Curative (C) | 2015-04-13 | 2015-05-04 | Capecitabine | N | N | 240035021 | PACLITAXEL |
| 240007909 | 240004878 | null | 71.7 | Adjuvant (A) | 2015-12-08 | 2015-12-30 | FCR IV - Cycle 1 | null | N | 240035029 | FLUOROURACIL + MITOMYCIN + RT |
| 240007910 | 240010705 | 1.75 | 55.299 | Curative (C) | 2017-10-24 | 2017-10-28 | CHOP R + METHOTREXATE | 1 | N | 240035032 | ABVD |
| 240007911 | 240004879 | 1.69 | 61 | null | null | 2014-01-03 | Carboplatin + Topotecan | N | Y | 240035034 | BEVACIZUMAB + CISPLATIN + PACLITAXEL |
| 240007912 | 240004880 | 1.63 | 67.2 | Adjuvant (A) | 2015-09-16 | 2015-09-20 | PACLITAXEL | N | Y | 240035039 | CYTARABINE |
| 240007913 | 240010706 | 1.65 | 74.6 | Neo-adjuvant (N) | 2015-02-15 | 2015-02-23 | CISPLATIN + ETOPOSIDE | N | N | 240035043 | CHLVPP |
| 240007914 | 240010706 | 1.72 | null | Palliative (P) | 2016-06-14 | 2016-07-02 | Erlotinib | 2 | N | 240035043 | FBC |
| 240007915 | 240004881 | 1.68 | 64 | Unknown (U) | 2016-10-11 | 2016-10-22 | Cyclophosphamide oral | N | N | 240035056 | PACE-BOM |
| 240007916 | 240010707 | 1.6 | 68 | Curative (C) | 2014-06-17 | 2014-06-21 | METHOTREXATE | N | N | 240035062 | mEOC TRIAL |
| 240007917 | 240004882 | 1.72 | 40.2 | Adjuvant (A) | 2014-11-15 | 2014-11-17 | CYCLO + RITUXIMAB + VINCRISTINE | N | N | 240035063 | ABVD |
| 240007918 | 240004882 | 1.64 | 72.6 | Curative (C) | 2014-02-07 | 2014-02-10 | Cisplatin + Topotecan | 2 | N | 240035063 | FLAG + IDARUBICIN |
| 240007919 | 240004882 | 1.66 | 89 | Disease modification (D) | 2014-06-12 | 2014-06-12 | Methotrexate intrathecal | N | N | 240035063 | METHOTREXATE |
| 240007920 | 240004883 | 1.64 | 80.7 | Palliative (P) | 2014-07-30 | 2014-07-30 | Carboplatin + Pemetrexed | Y | N | 240035085 | PACLITAXEL |
| 240007921 | 240004883 | 1.69 | null | null | 2015-12-17 | 2015-12-24 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | N | null | 240035085 | ADE |
| 240007922 | 240004884 | 1.6 | 76.7 | Curative (C) | 2015-09-19 | 2015-09-19 | Fluorouracil+Mitomycin+RT (Anal Ca) | Y | N | 240035091 | PILOT TRIAL |
| 240007923 | 240004884 | 1.65 | 59.4 | Palliative (P) | 2014-08-20 | 2014-08-20 | FLAG | N | N | 240035091 | CISPLATIN + ETOPOSIDE |
| 240007924 | 240004885 | null | 68.1 | Curative (C) | 2014-07-27 | 2014-11-10 | ABVD | N | N | 240035099 | NHL 2003 |
| 240007925 | 240004885 | null | 94.6 | Palliative (P) | 2013-05-11 | 2013-05-12 | GemCarbo Days 1+8 | N | N | 240035099 | FLAG + IDARUBICIN |
| 240007926 | 240004886 | 1.76 | null | Disease modification (D) | 2014-04-23 | 2014-04-23 | Cytarabine HD + Rituximab | N | N | 240035104 | ERLOTINIB |
| 240007927 | 240004887 | 1.67 | 72.6 | Curative (C) | null | 2013-02-16 | GEMCARBO | null | N | 240035106 | BEVACIZUMAB + CISPLATIN + PACLITAXEL |
| 240007928 | 240004887 | 1.8 | 89 | Curative (C) | 2017-12-09 | 2017-12-16 | AML 19 TRIAL | N | null | 240035106 | BCG |
| 240007929 | 240004888 | null | 92 | Neo-adjuvant (N) | 2014-10-05 | 2014-10-05 | Cladribine (subcut) 5 days | 02 | null | 240035108 | FCR |
| 240007930 | 240004889 | 1.52 | 62.9 | Neo-adjuvant (N) | 2016-12-18 | 2016-12-18 | Bortezomib + CYCLOPHOSPHAMIDE | N | null | 240035109 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 240007931 | 240004890 | 1.8 | 80 | Curative (C) | 2015-12-11 | 2016-01-12 | RIALTO TRIAL | 02 | N | 240035110 | UKALL2011 |
| 240007932 | 240004890 | 1.67 | 60.4 | Curative (C) | 2016-01-28 | 2016-02-08 | CHOP R + METHOTREXATE | 02 | N | 240035110 | DOCETAXEL |
| 240007933 | 240004891 | 1.75 | null | Palliative (P) | 2013-02-06 | 2013-02-15 | ATG + Busulfan + Fludarabine | N | null | 240035121 | AML19 TRIAL |
| 240007934 | 240004892 | 1.48 | 82.3 | Palliative (P) | 2016-08-23 | 2016-08-24 | CISPLATIN + FLUOROURACIL + RT | 1 | N | 240035129 | CISPLATIN + TOPOTECAN |
| 240007935 | 240004892 | null | 59.6 | Neo-adjuvant (N) | 2014-04-24 | 2014-04-28 | DOXORUBICIN | N | null | 240035129 | CISPLATIN + ETOPOSIDE |
| 240007936 | 240004893 | null | 76 | Curative (C) | 2013-07-29 | 2013-08-19 | CISPLATIN + FLUOROURACIL + RT | null | N | 240035134 | METHOTREXATE INTRATHECAL |
| 240007937 | 240004894 | null | 77.6 | null | null | 2017-04-30 | Enzalutamide | null | null | 240035137 | CYTARABINE |
| 240007938 | 240004895 | 1.75 | null | Curative (C) | null | 2013-07-31 | AML16 DA 3+10 | N | N | 240035143 | METHOTREXATE |
| 240007939 | 240010715 | 1.69 | 71 | Curative (C) | 2013-08-26 | 2013-08-27 | CISPLATIN + ETOPOSIDE | 2 | N | 240035146 | VEPEMB |
| 240007940 | 240004896 | null | 70 | Curative (C) | 2014-05-11 | 2014-06-09 | FEC + DOCETAXEL | N | N | 240035156 | CISPLATIN + TOPOTECAN |
| 240007941 | 240004897 | 1.77 | 0 | Palliative (P) | 2014-05-13 | 2014-05-16 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 02 | N | 240035157 | GEMCITABINE + VINORELBINE |
| 240007942 | 240004898 | null | 101.9 | Palliative (P) | 2018-02-27 | 2018-02-27 | Imatinib 400mg | N | N | 240035169 | DOXORUBICIN |
| 240007943 | 240004899 | 1.68 | null | Disease modification (D) | 2013-09-08 | 2013-09-20 | Cisplatin + Paclitaxel | 02 | N | 240035176 | CLADRIBINE |
| 240007944 | 240004899 | 0 | 62.2 | Palliative (P) | null | 2017-05-19 | ABVD | N | N | 240035176 | FCR |
| 240007945 | 240004899 | 1.83 | 72 | Palliative (P) | 2014-06-26 | 2014-06-28 | Methotrexate intrathecal | 02 | N | 240035176 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240007946 | 240004900 | 1.48 | 94.7 | Curative (C) | 2015-07-08 | 2015-07-11 | Cyclophosphamide + Dex + Rituximab | 02 | N | 240035193 | CHOP R + METHOTREXATE |
| 240007947 | 240004901 | 1.59 | 65.9 | Curative (C) | 2016-08-31 | 2016-09-09 | CISPLATIN + ETOPOSIDE | N | N | 240035194 | CISPLATIN + ETOPOSIDE |
| 240007948 | 240004901 | 1.77 | 103 | Curative (C) | 2018-09-12 | 2018-09-22 | CHOEP - 14 days | N | N | 240035194 | ABVD |
| 240007949 | 240004902 | 1.68 | 36.55 | Neo-adjuvant (N) | 2015-08-02 | 2015-08-18 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 240035203 | CVP |
| 240007950 | 240010718 | 1.66 | 64.7 | Curative (C) | 2018-03-22 | 2018-04-13 | Methotrexate intrathecal | N | null | 240035204 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240007951 | 240010718 | null | null | Palliative (P) | 2016-10-15 | 2016-10-28 | Paclitaxel 7 day | 02 | N | 240035204 | CISPLATIN + FLUOROURACIL |
| 240007952 | 240010718 | 0 | 56.5 | Curative (C) | 2014-01-07 | 2014-01-12 | FCR IV - Cycle 1 | N | N | 240035204 | BEVACIZUMAB |
| 240007953 | 240004903 | 1.72 | 58 | Palliative (P) | 2017-08-10 | 2017-08-10 | Bevacizumab 15mg/kg | N | N | 240035220 | CISPLATIN + ETOPOSIDE |
| 240007954 | 240004903 | 1.6 | 86.8 | Curative (C) | null | 2016-05-03 | ALL UKALL60+ TRIAL | N | N | 240035220 | BEVACIZUMAB |